A non-syndromic intellectual disability associated with a de novo microdeletion at 7q and 18p, microduplication at Xp, and 18q partial trisomy detected using chromosomal microarray analysis approach by Irene Pinto et al.
Pinto et al. Molecular Cytogenetics 2014, 7:44
http://www.molecularcytogenetics.org/content/7/1/44CASE REPORT Open AccessA non-syndromic intellectual disability associated
with a de novo microdeletion at 7q and 18p,
microduplication at Xp, and 18q partial trisomy
detected using chromosomal microarray analysis
approach
Irene Plaza Pinto1,3, Lysa Bernardes Minasi1,3, Alex Silva da Cruz1,2, Aldaires Vieira de Melo4,
Damiana Míriam da Cruz e Cunha1,3, Rodrigo Roncato Pereira2, Cristiano Luiz Ribeiro1, Claudio Carlos da Silva1,3,6,
Daniela de Melo e Silva1,5 and Aparecido Divino da Cruz1,2,3,4,6*Abstract
Background: Chromosome abnormalities that segregate with a disease phenotype can facilitate the identification
of disease loci and genes. The relationship between chromosome 18 anomalies with severe intellectual disability
has attracted the attention of cytogeneticists worldwide. Duplications of the X chromosome can cause intellectual
disability in females with variable phenotypic effects, due in part to variations in X-inactivation patterns. Additionally,
deletions of the 7qter region are associated with a range of phenotypes.
Results: We report the first case of de novo microdeletion at 7q and 18p, 18q partial trisomy, microduplication at
Xp associated to intellectual disability in a Brazilian child, presenting a normal karyotype. Karyotyping showed any
chromosome alteration. Chromosomal microarray analysis detected a de novo microdeletion at 18p11.32 and 18q
partial trisomy, an inherited microdeletion at 7q31.1 and a de novo microduplication at Xp22.33p21.3.
Conclusions: Our report illustrates a case that presents complex genomic imbalances which may contribute to a
severe clinical phenotypes. The rare and complex phenotypes have to be investigated to define the subsets and
allow the phenotypes classification.
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Chromosome abnormalities that segregate with a disease
phenotype can facilitate the identification of disease loci
and genes. The relationship between chromosome 18
anomalies with severe intellectual disability (ID) has
attracted the attention of cytogeneticists worldwide [1].
Moreover, the partial trisomy of the chromosome 18 is a
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unless otherwise stated.variant and less severe form of Edwards’s Syndrome
(OMIM 300484). For this condition, the severity of the
symptoms and the phenotype is highly variable depend-
ing on the extension of chromosome involvement and
the level of compromised cells and tissues [2].
Eighty percent of the cases of Edwards’s Syndrome
present full trisomy, the other 20% present mosaic or
partial 18 trisomy [1]. After birth, mosaic chromosomal
abnormalities are essentially identified among individuals
with phenotypic manifestation of recognizable aneu-
ploidy (chromosomal) syndromes. Mosaic aneuploidy in-
volving 18 chromosome was classified as a frequent
mosaic autosomal aneuploidy [3].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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chromosome. Duplications of the X chromosome can
cause ID in females with variable phenotypic effects, due
in part to variations in X-inactivation patterns [4]. It has
been estimated that up to 30% of genes on the short
arm of the X chromosome could escape inactivation and
undergo gene expression in cells and tissues [5]. Dele-
tions of the 7qter region are associated with a range of
phenotypes, and clinical findings comprise low birth
weight, mental retardation, development delay, facial
dysmorphisms and genitourinary malformations [6,7].
Here in we report the first case of de novo microdele-
tion at 7q and 18p, 18q partial trisomy, microduplication
at Xp associated to a non-syndromic intellectual disabil-
ity in a Brazilian child, presenting a normal karyotype.
Case presentation
A 4-years old female patient born to non-consanguineous
parents, at 39 weeks gestation to a 33-year-old mother
and 47-year-old father, and her birth weight was 2325 g.
Child delivery was carried out through a caesarean section
procedure. Physical examination of the proband reveled
delayed psychomotor development, severe intellectual dis-
ability, and a height of 94,5 cm (<7rd), a weight of 9500 g
(<7rd). Her craniofacial dysmorphisms included an oblong
face with a prominent forehead/frontal bossing, a bulbous
nasal tip on a small nose and abnormal teeth. She also had
hypertelorism, lower ear implantation and limb weakness.
The family history was unremarkable on both sides.
Results
Karyotyping at about 550 band resolution showed the
proband with a female karyotype (46,XX), without anyFigure 1 G-banded karyotype. Displaying no numerical or structural karysuggestion of chromosome alteration (Figure 1). Her
parents also presented normal karyotype. CMA detected
four genomic imbalances in the patient’s genome, corre-
sponding to a de novo 1.23 Mb microdeletion at 18p11.32
(136,226-1,369,804)x1 [NCBI 37.3/hg19] with 30%
mosaicism, a 18q partial trisomy with 40% mosaicism
(Figure 2), an inherited 386.73 kbp microdeletion at
7q31.1(110,923,434-111,310,159)x1 [NCBI 37.3/hg19]
and a de novo 25.72 Mb microduplication at Xp22.33p21.3
(168,546-25,887,307)x3 [NCBI 37.3/hg19] (Figure 3). The
progenitor’s CMA confirmed de novo genomic imbalances
in their child (Table 1).
Discussion
In our study, the use of microarray analyses allowed the
identification of genomic rearrangements in a girl severely
affected with intellectual disability, multiple congenital ab-
normalities and intense dysmorphology, despite her nor-
mal karyotype.
CMA showed 386.73 kbp microdeletion at 7q31.1,
inherited from her mother, likely pathogenic because
harbor IMMP2L gene that, according to authors, dele-
tions involving this gene have been associated with at-
tention deficit hyperactivity disorder (ADHD) [8], autism
[9], and Tourette syndrome [10]. Moreover, the IMMP2L
gene was also found in inherited rare CNV-associated
gene set in ADHD patients [8].
Furthermore, we observed two genomic imbalances at 18
chromosome. A de novo mosaic microdeletion at 18p11.32,
a genomic imbalance comprising 11 genes, and the gene
only was ADCYAP1, also known as PACAP, related to intel-
lectual disability [11]. Additionally, the monosomy of 18p
chromosome refers to a chromosomal disorder, resultingotype deviations (46,XX).
Figure 2 CMA depicts genomic imbalances in chromosome 18. The microarray profile of the 18p11.32 microdeletion is represented by the
bold red line and the 18q partial trisomy is represented by the bold blue line, both in mosaicism.
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clinical features frequently include mild to moderate men-
tal retardation, short stature, and speech delay [12].
On the other hand, the most relevant alteration ob-
served was a de novo 18q partial trisomy with 40% mo-
saicism. The degree of clinical manifestations in a
patient who presents partial trisomy of chromosome 18
is variable, generally include a relatively mild phenotype
with a high survival rate [1]. In the partial trisomy form,
only a segment of the chromosome 18q is present in
triplicate, often resulting from a balanced translocation
or an inversion carried by one parent. This type of tri-
somy accounts for approximately 2% of cases presenting
with the Edward’s phenotype. The location and the
extent of the triplicated segment and the possibleassociated deletion of genomic material due to unbal-
anced translocation can explain the variable phenotype
associated with partial trisomies [13].
The clinical findings are highly variable in a phenotypic
spectrum that spans from the absence of dysmorphic fea-
tures with normal intelligence to the complete trisomy 18
syndrome. Thus, clinical and cytogenetic diagnostic of
chromosome 18 partial trisomy in mosaic state is a chal-
lenge for both medical and laboratory personnel. The etio-
logic factors for mosaic trisomy 18 are unknown, but
advanced maternal age is an important factor that in-
creases the risk of chromosomal nondisjunction in off-
spring. Nevertheless, the association between paternal age
(40 years of age or older) and chromosomal abnormalities
may be investigated [14,15].
Figure 3 CMA data of the proband with genomic imbalances in 7 and X chromosomes. Analysis showing (A) a deletion segment at 7q31.1
and (B) duplication segment at Xp22.33p21.3 from patient.
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at Xp22.33p21.3, involving 109 genes. However, only 8
OMIM morbid genes have been described in association
with intellectual disability, namely: NLGN4X, AP1S2,
NHS, CDKL5, RPS6KA3, MBTPS2, SMS, ARX. Intersti-
tial duplications of the short arm of the X chromosome
have been rarely described. Female carriers of parti-
al Xp duplication exhibit variable developmental defe-cts, because of random or selective inactivation of X
chromosome [16].
The encoded protein NLGN4X belongs to a family of
neuronal cell surface proteins and mutations in this gene
has been associated with autism and Asperger’s Syndrome
(OMIM 300497). Pathogenic mutations in the X-linked
NLGN4X in autism spectrum disorders and/or mental re-
tardation are rare [16].
Table 1 Clinical and molecular features of patient
Clinical
features*
















Loss 7q31.1 0.39 265 7q31.1
(110,923,434-
111,310,159)x1
1 IMMP2L Inherited mat LP
Loss 30 18p11.32 1.23 1400 18p11.32(136,
226-1,369,804)x1
11 ADCYAP1 de novo LP
Gain 40 18q11.1 53197 18q11.1q23
(18,608,373-
78,014,123)x2-3
18q Partial Trissomy de novo Pathogenic







*GDD = Global Developmental Delay; MS =Multiple Stigmas, MCA =Multiple Congential Anomalies; **Genes related to ID/Autsm; yo = years old; LP = Likely
Pathogenic.
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adaptin protein family, disruption of the AP1 complex via
mutations in AP1S2 could disrupt normal neurotransmit-
ter processing within the synapse [17].
The encoded protein NHS may function during the
development of the eyes, teeth and brain. Mutations in
the NHS gene are related to Nance-Horan’s Syndrome
(OMIM 302350), which is characterized by bilateral con-
genital cataracts, dental anomalies, craniofacial abnor-
malities and, in some cases, mental retardation. It is
important in the limbic system, given the range of
neuropsychological abnormalities, including mental re-
tardation, autism, aggression, anxiety, stereotypical be-
havior and mood disturbance [18].
The CDKL5 gene is a member of Ser/Thr kinase fam-
ily and encodes a phosphorylated protein with a kinase
activity. According to some researchers, female with
CDKL5 mutations experience no regression and the
delay of psychomotor development is present since birth
[19]. Alterations involving CDKL5 have also been found
in some patients with Hanefeld variants, a congenital
form of Rett Syndrome, an X-linked dominant severe
neurodevelopmental disorder that affect almost exclu-
sively girls. Moreover, mutation or chromosomal translo-
cations involving CDKL5 have also been identified in
patients with infantile spasms associated with mental re-
tardation and in West’s Syndrome (OMIM 308350) pa-
tients [20].
The RPS6KA3 gene encodes a member of the RSK
(ribosomal S6 kinase) family of Ser/Thr kinases. The
activity of this protein has been implicated in controll-
ing cell growth and differentiation. Mutations in the
RPS6KA3 gene were first reported in Coffin-Lowry Syn-
drome (OMIM 303600) [21], and this gene also affects
nonsyndromic X-linked intellectual disability and non-
syndromic X-linked intellectual disability without bone
abnormalities [22]. In addition, one case was reported in
which a boy with mild ID and a maternally inherited
microduplication at Xp22.12. The duplicated regionincluded RPS6KA3, a key gene related to mental retard-
ation or intellectual disability in humans [21].
The MBTPS2 gene encodes a intramembrane zinc
metalloprotease, which is essential in development, and
mutation in this gene can cause the Ichthyosis Follicu-
laris, Atrichia, and Photophobia Syndrome, with or with-
out BRESHECK Syndrome (OMIM 308205), which is an
X-linked multiple congenital anomaly disorder with vari-
able severity, and some patients have additional features,
including mental retardation [23].Conclusion
This is the first case of a Brazilian child reported with
complex genomic alterations involving chromosomes 7,
18 and X that went undetected by banding cytogenetics.
However, the complex rearrangements were detected by
chromosomal microarray analysis using clinical relevant
probes. Synergistic effects from the rare genomic imbal-
ances is likely responsible for the severe observed clin-
ical phenotype in the proband. Further studies are
required to define the role of the genes presented in this
report to define the physiopathology of phenotypes simi-
lar to the one described here.
The rare and complex phenotypes need to be investi-
gated to define the subsets and allow the phenotypes
classification. Furthermore, this will allow adequate clin-
ical management and a better follow up of the proband
and the family.Materials and methods
Following the Pontif ícia Universidade Católica de Goiás
ethics approval (CAAE 0051.0.168.000-11) an informed
consent was signed and peripheral blood was obtained
for cytogenetic studies including karyotyping and CMA.
Conventional cell culture, harvesting, and GTG banding
followed standardized procedures [24]. Chromosome
analyses were done using the software IKAROS® (Meta-
systems Corporation, Germany).
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on both patient and her parents, in order to determine
the origin of potential DNA imbalances, either de novo
or inherited. Genomic DNA was isolated from whole
blood using QIAamp® DNA Mini kit (Qiagen, Germany).
Total DNA (250 ng) was amplified, labeled, and hybrid-
ized using GeneChip CytoScanTM HD array protocols
(Affymetrix, USA) according to the manufacturer’s in-
structions. The array was designed specifically for cyto-
genetic research, including ≈ 2,696,550 CNV markers,
743,304 SNP markers, and > 1,953,246 non-polymorphic
markers. CEL files obtained by scanning the arrays were
analyzed using the Chromosome Analysis Suite (ChAS)
software (Affymetrix, USA). Gains and losses that af-
fected a minimum of 50 and 25 markers, respectively, in
a 100 kb length were initially considered.
CNVs were classified according to their nature, based
on [25,26]. In summary, the CNVs found in each patient
and their biological parents were compared with gen-
omic variants in public databases, including Database of
Genomic Variants (DGV), Database of Chromosomal
Imbalance and Phenotype in Humans using Ensemble
Resources (DECIPHER), and CytoScan™ HD Array Data-
base. CNVs were classified as pathogenic, likely patho-
genic, and of unknown clinical significance, according to
[24,25]. CMA analysis followed the manufacter’s instruc-
tion regarding mosaic, which follows the same principle
of a complete CNV, a mosaic call was made by the soft-
ware and included a clear result in SmoothSignal and
Allele Peaks.Consent
Written informed consent was obtained from the parents
of the patients for publication of this report and the ac-
companying images. A copy of the written consent is
available for review by the Editor-in-Chief of this journal.
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